ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants

NCT06293742 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: ECC5004
DRUG: Midazolam
DRUG: Rosuvastatin
DRUG: Digoxin
DRUG: Atorvastatin

Sponsor

Eccogene